The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is an autoimmune demyelinating disease and a common cause of neurological disability in young adults. The modest heritability of MS reflects complex genetic effects and multifaceted gene-environment interactions. The human leukocyte antigen (HLA) region is the strongest susceptibility locus for MS, but a genome-wide association study recently identified new susceptibility genes. Progress in high-throughput genotyping and sequencing technologies and a better understanding of the structural organization of the human genome, together with powerful brain-imaging techniques that refine the phenotype, suggest that the tools could finally exist to identify the full set of genes influencing the pathogenesis of MS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“do not seem to have a significant genetic component”
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439 · cited 1×
“It is of considerable interest that a recent clinical trial of an anti-B-cell therapy in MS showed marked effects in reducing bursts of focal inflammatory disease activity, establishing the vital importance of B cells as triggers of MS attack”
BackgroundSelf-citationWacholder, S., Chanock, S., Garcia-Closas, M., El ghormli, L., & Rothman, N. (2004) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djh075 · Cited by 1,754
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Research works printed but not linked: 3
- Hauser, S. L. & Goodin, D. S. in Harrison's Principle of Internal Medicine 17th edn (eds Fauci, A. D. et al.) 2611–2620 (McGraw Hill, New York, 2008).
- Kantarci, O. H. et al. Men with MS transmit the disease more often to their children then women: the Carter effect. Mult. Scler. 10, S203 (2004).
- Anderson, A. & Karlsson J. Genetic of experimental autoimmune encephalomyelitis in the mouse. Arch. Immunol. Ther. Exp. (Warz) 52, 316–325 (2004).
Cited by
Items 201–300 of 347
Farrokhi, M., Masoudifar, A., Derakhshan, A., Saadatmand, S., Rouhi-Boroujeni, H., Etemadifar, M., Rezaei-Zarji, S., Javid, A., Nobakht, R., Deyhimi, M. S., et al. (2017) · Immunological Investigations · doi:10.1080/08820139.2016.1268154 · Cited by 15
“large number of studies have addressed the human leukocyte antigen (HLA) genes located on chromosome 6 as the most strongly linked genetic factor for the risk of MS (Oksenberg et al., 2008).”
BackgroundRetractedAderinto, N., Muili, A. O., & Opanike, J. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000560 · Cited by 14
ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment
Malishkevich, A., Leyk, J., Goldbaum, O., Richter‐Landsberg, C., & Gozes, I. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0640-4 · Cited by 15
Autoimmune Disease Prevalence in a Multiple Sclerosis Cohort in Argentina
Farez, M., Aguirre, M. E. B., Varela, F., Köhler, A., & Correale, J. D. (2014) · Multiple Sclerosis International · doi:10.1155/2014/828162 · Cited by 14
Sex-specific environmental influences affecting MS development
Correale, J. D., Aguirre, M. E. B., & Farez, M. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.02.006 · Cited by 21
Biomarkers of treatment response in multiple sclerosis
Buck, D., & Hemmer, B. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.874289 · Cited by 17
“Both environmental and genetic factors are supposed to contribute to the pathogenesis of MS [16–19].”
BackgroundPrevalence of Multiple Sclerosis (MS) in Zanjan Province of Iran
Ghajarzadeh, M., Foroushani, A., Ghezelbash, P., Ghoreishi, A., Maghbooli, M., Yousefi, M., Rahgoshai, B., Maemodan, F. G., Mohammadifar, M., & Sahraian, M. A. (2020) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_419_19 · Cited by 12
“International Journal of Preventive Medicine 2020, 11: 1164 Genetics (ethnicity) is another predisposing factor in MS.”
InfluentialThe role of the Epstein–Barr Virus receptor CD21 in Multiple Sclerosis
Toepfner, N., Cepok, S., Grummel, V., & Hemmer, B. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.11.002 · Cited by 12
Zhang, D., Wang, L., Zhang, R., & Li, S. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.10.007 · Cited by 12
Nikolopoulos, G. K., Masgala, A., Tsiara, C., Limitsiou, O. K., Karnaouri, A., Dimou, N. L., & Bagos, P. G. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03355.x · Cited by 13
“Therefore, there is still room for further epidemiologic research focusing on individuals of various racial descents, which, together with improvements in genotyping technology and a better understanding of the structural organization of human genome [80], will lead to new avenues for formulating a more comprehensive…”
BackgroundRole of CD4+ T Cells in the Pathophysiology of Multiple Sclerosis
Sato, F., Omura, S., Jaffe, S. L., & Tsunoda, I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800763-1.00004-x · Cited by 12
“Genes, including those for IL-2 receptor α chain (CD25), IL-7 receptor α chain (CD127), and TNF receptors may influence the risk of developing MS (Oksenberg, Baranzini, Barcellos, & Hauser, 2001; Oksenberg, Baranzini, Sawcer, & Hauser, 2008; Rose, 2009) .”
BackgroundDesign, methodological issues and participation in a multiple sclerosis case-control study
Williamson, D., Marrie, R. A., Ashley‐Koch, A. E., Schiffer, R. B., Trottier, J., & Wagner, L. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01629.x · Cited by 10
“The most convincing evidence for a genetic component comes from twin studies that showed a 20- to 40-fold increased risk in monozygotic twins as compared with that of the general population (1).”
BackgroundElucidating the Molecular Basis of Multiple Sclerosis and Understanding the Disease Pathophysiology
Mohammed, E. M. A. (2016) · Immunome Research · doi:10.4172/1745-7580.10000125 · Cited by 14
“Thus, memory B-cells that persist for years and produce anti-EBV antibodies can react with CNS antigens and cause demyelination and tissues damage even after clearance of infection [102-105].”
BackgroundOkolicsanyi, R. K., Bluhm, J., Miller, C., Griffiths, L. R., & Haupt, L. M. (2020) · Human Genomics · doi:10.1186/s40246-020-00264-6 · Cited by 9
“MS is a complex genetic disease characterised by polygenic heritable components and multifaceted geneenvironment interactions and factors [11].”
BackgroundSharafkhah, M., Mosayebi, G., Massoudifar, A., Seddigh, S. H., Abdolrazaghnejad, A., Alamdara, M. A., Mokarian, P., Mohammadbeigi, A., & Ebrahimi-Monfared, M. (2022) · Neurology India · doi:10.4103/0028-3886.338707 · Cited by 10
Molecular genetic studies of multiple sclerosis in the portuguese population.
Bettencourt, A., SILVA, A. C. F. D., Costa, P., & da Silva, B. M. (2012) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 12
Mathur, D., Ureña-Peralta, J., López-Rodas, G., Casanova, B., Coret-Ferrer, F., & Burgal-Marti, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00375 · Cited by 10
“Therefore it is essential to pre-validate the expression stability of reference genes to accurately normalize the gene expression data.”
BackgroundIntrinsic Toll-like receptor signalling drives regulatory function in B cells
Shen, P., Lampropoulou, V., Stervbo, U., Hilgenberg, E., Ries, S., Mecqinion, A., & Fillatreau, S. (2013) · Frontiers in Bioscience-Elite · doi:10.2741/e597 · Cited by 12
“T cells might participate in pathogenesis of RR-MS because polymorphisms in genes controlling T cell activation (human leukocyte antigen class II, IL-2 receptor, or IL-7 receptor) are associated with disease susceptibility (17).”
BackgroundCarlson, R. J., Doucette, J. R., Knox, K. B., & Nazarali, A. J. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.10.008 · Cited by 10
“approximately 1–2 in 1000 [9].”
Clinical pathways for the care of multiple sclerosis patients
Oreja‐Guevara, C., Miralles, A., García-Caballero, J., Noval, S., Gabaldón, L., Esteban-Vasallo, M. D., García-Matres, M. J., Bayón, C., Royo, A., González, A., et al. (2010) · Neurología (English Edition) · doi:10.1016/s2173-5808(10)70031-6 · Cited by 9
United Europeans for Development of Pharmacogenomics In Multiple Sclerosis Network
Vandenbroeck, K., Comabella, M., Tolosa, E., Goertsches, R. H., Brassat, D., Hintzen, R. Q., Infante‐Duarte, C., Favorov, A. V., Escorza, S., Palácios, R., et al. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.33 · Cited by 9
Self-citationJAK-STAT Lodges in Multiple Sclerosis: Pathophysiology and Therapeutic Approach Overview
Hamid, K. M., Isiyaku, A., Kalgo, M. U., Yahaya, I. S., & Mirshafiey, A. (2017) · OALib · doi:10.4236/oalib.1103492 · Cited by 11
“5 million people worldwide [4] and is commonly found in young adults, and it is more common in women [5].”
BackgroundGenome-wide association studies: a powerful tool for neurogenomics
Cowperthwaite, M. C., Mohanty, D., & Burnett, M. G. (2009) · Neurosurgical FOCUS · doi:10.3171/2010.10.focus09186 · Cited by 9
Computational modeling of brain pathologies: the case of multiple sclerosis
Pappalardo, F., Rajput, A.-M., & Motta, S. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw123 · Cited by 10
Tempest, A., Veettil, S. K., Maharajan, M. K., Earl, J. C., Ngorsuraches, S., & Chaiyakunapruk, N. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103834 · Cited by 8
Constructing human phenome-interactome networks for the prioritization of candidate genes
Chen, Y., Gan, M., Jiang, R., & Zhang, W. (2012) · Statistics and Its Interface · doi:10.4310/sii.2012.v5.n1.a12 · Cited by 7
“The ultimate goal of identifying genetic factors that are responsible for complex diseases is to identify and characterize biological pathways and processes critical to the disorder [62].”
BackgroundVandenbark, A. A., Meza‐Romero, R., Wiedrick, J. T., Gerstner, G., Seifert, H. A., Kent, G., Piecychna, M., Benedek, G., Bucala, R., & Offner, H. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104561 · Cited by 7
Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male mice
Vandenbark, A. A., Meza‐Romero, R., Wiedrick, J. T., Gerstner, G., Headrick, A., Kent, G., Seifert, H. A., Benedek, G., Bucala, R., & Offner, H. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104439 · Cited by 7
“The predominant genetic effect in MS has been attributed to the major histocompatibility complex (MHC) which encodes highly polymorphic proteins that bind peptides for presentation to CD4+ and CD8+ T-cell receptors [1,2].”
BackgroundResident T cells in the healthy and multiple sclerosis brain
Smolders, J., Hsiao, C., Huitinga, I., & Hamann, J. (2026) · Trends in Immunology · doi:10.1016/j.it.2025.12.006 · Cited by 8
Mohammadi-Kordkhayli, M., Sahraian, M. A., Ghorbani, S., Mansouri, F., Talebi, F., Noorbakhsh, F., & Saboor-Yaraghi, A. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03427-3 · Cited by 9
Shahra, M., Keshavarz, H., Sahraian, M. A., Shojaee, S., Heidari, A., Alimi, R., & Teimouri, A. (2023) · Iranian Journal of Parasitology · doi:10.18502/ijpa.v18i2.13182 · Cited by 8
“not clearly understood similar to other autoimmune diseases, combination of genetic proneness and environmental and lifestyle factors can lead to development of the disease (3).”
BackgroundJafari, N., Broer, L., Hoppenbrouwers, I. A., van Duijn, C. M., & Hintzen, R. Q. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510376778 · Cited by 6
“3, with the strongest effect originating from the HLA-DRB1*15 gene in the class II region.(20,21) HLA class I associations have been demonstrated,(11,22) but these were often credited to linkage disequilibrium (LD) with class II type.”
BackgroundPourhossein, M., Ghavimi, R., Ghaedi, K., Alesahebfosoul, F., Honardoost, M., & Maracy, M. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.145742 · Cited by 7
“[8,10,14] Most of these genes are investigated because they are presumed to be relevant to the pathogenesis of MS based on the function of the gene.[8,9] However, additional genes complicated in MS predisposition and in the change of its clinical course stay to be identified.”
InfluentialGenetics for understanding and predicting clinical progression in multiple sclerosis
Depaz, R., Granger, B., Cournu‐Rebeix, I., Bouafia, A., & Fontaine, B. (2011) · Revue Neurologique · doi:10.1016/j.neurol.2011.02.043 · Cited by 6
“Heterogeneity of MS severity might reflect the diversity of biological processes involved in myelin sheath and axons injury (neuroinflammation, neurodegeneration), and repair (remyelination, axonal growth, brain plasticity) (Oksenberg et al., 2008).”
IGHV4-39 deletion polymorphism does not associate with risk or outcome of multiple sclerosis
Watson, C. T., Ramagopalan, S. V., Morrison, K., Ebers, G. C., & Breden, F. J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.04.012 · Cited by 6
“The exact cause of MS remains undefined, although both genetic and environmental factors are known to influence disease risk (Oksenberg et al., 2008; Ebers, 2008; Ramagopalan et al., 2009).”
BackgroundEfficacy and Toxicity of Rituximab in Multiple Sclerosis
Tolou–Ghamari, Z. (2015) · Archives of Neuroscience · doi:10.5812/archneurosci.30107 · Cited by 6
“Even though polymorphisms in genes scheming T-cell commencement demonstrate the strong relationship with illness vulnerability, B cell activation is ,besides being a common irregularity in Relapsing-Remitting MS (RR-MS), tinted by the attendance of intrathecal oligoclonal immunoglobulin bands in > 90% of patients (9,…”
BackgroundAssociation Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population
Şimşek, H., Geckin, H., Şensöz, N. P., List, E. O., & Arman, A. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1205-0 · Cited by 7
Baranzini, S. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00070-7 · Cited by 7
Self-citationAnimal Models of Multiple Sclerosis
Sato, F., Omura, S., Martinez, N. E., & Tsunoda, I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811709-5.00003-x · Cited by 9
Pennell, C. E., Palmer, L. J., Knight, B. S., Relton, C. L., & Lye, S. J. (2009) · KARGER eBooks · doi:10.1159/000221166 · Cited by 6
Kallaur, A. P., Oliveira, S. R., Simão, A. N. C., de Almeida, E. R. D., Morimoto, H. K., Lopes, J. M., Pelegrino, L. M., de Pereira, W. L. C. J., Alfieri, D. F., Andrade, R., et al. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0287-6 · Cited by 8
Notions de génétique moléculaire pour comprendre l’hérédité
Lamoril, J., Ameziane, N., Deybach, J., Bouizegarène, P., & Bogard, M. (2008) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2008.10.005 · Cited by 8
Pourhossein, M., Ghavimi, R., Alsahebfosoul, F., & Ghaedi, K. (2014) · Open Journal of Genetics · doi:10.4236/ojgen.2014.45038 · Cited by 6
“Given complex genetic effects and multifaceted gene-environment interaction nature of MS, frequencies of genetic SNP polymorphisms are different among ethnic populations [8].”
BackgroundRole of diet, gut microbiota, and metabolism in multiple sclerosis and neuromyelitis optica
Okuno, T., Kinoshita, M., Ishikura, T., & Mochizuki, H. (2019) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12499 · Cited by 5
“have shown that human leukocyte antigen (HLA) alleles, including DRB1*1501, are related to susceptibility to MS.(2,3) These major histocompatibility complex class II genes are involved in antigen presentation to CD4 T cells, which leads to autoimmunity in the central nervous system.”
BackgroundInfluentialMirahmadi, M., Naeimipour, S., Amirlatifi, R., & Shahbazi, M. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100392 · Cited by 5
Estudos Genéticos em Doentes Portugueses com Esclerose Múltipla
Bettencourt, A., SILVA, A. C. F. D., Costa, P., & da Silva, B. M. (2012) · Acta Médica Portuguesa · doi:10.20344/amp.66 · Cited by 6
Diseño de una vía clínica para la atención a los pacientes con esclerosis múltiple
Oreja‐Guevara, C., Miralles, A., García-Caballero, J., Noval, S., Gabaldón, L., Esteban-Vasallo, M. D., García-Matres, M. J., Bayón, C., Royo, A., González, A., et al. (2010) · Neurología · doi:10.1016/s0213-4853(10)70003-7 · Cited by 5
Fontes-Dantas, F. L., Cardoso, R. D. C., Domingues, V., & Fernandes, G. G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-04357-3_4 · Cited by 5
Gene expression profiling of early Parkinson’s disease patient reveals redox homeostasis
Zhang, L., He, Y., Lei, K., Fang, Z., Li, Q., Su, J., Nie, Z., Xu, Y., & Jin, L. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135893 · Cited by 4
Alrashoudi, R. H. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/172240 · Cited by 5
George, S., & White, J. H. (2014) · Australian Occupational Therapy Journal · doi:10.1111/1440-1630.12154 · Cited by 4
Therapeutic Approaches toward Multiple Sclerosis: Where Do We Stand and Where Are We Headed?
Moura, R. P., & Sarmento, B. F. C. C. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900070 · Cited by 4
Grabmer, C., Nachbauer, W., Schanda, K., Feurle, P., Loacker, K., Scholz, E., Schennach, H., Berger, T., Reindl, M., & Gassner, C. (2010) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01433.x · Cited by 6
PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
Hawker, K. (2010) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000389943.81981.3b · Cited by 4
“patterns in patients with MS.(31) The rare pattern IV subtype was characterized by an oligodendrogliopathy and was only seen in PPMS.”
BackgroundSaligrama, N., Noubade, R., Case, L. K., Poynter, M. E., & Teuscher, C. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.06.012 · Cited by 4
“Therefore, the role of innate immune cells, such as DCs or macrophages, in the pathogenesis of MS and EAE has to some extent been underappreciated despite the fact that MHC class II alleles (DRB1⁄ 1501) represent the majority of the genetic risk of developing MS [58].”
Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients
Lysandropoulos, A. P., Racapé, J., Holovská, V., & Toungouz, M. (2016) · Acta Neurologica Belgica · doi:10.1007/s13760-016-0716-0 · Cited by 7
Vitamin D and Multiple Sclerosis
Hayes, C. E., Nashold, F. E., Mayne, C. G., Spanier, J. A., & Nelson, C. D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10095-2 · Cited by 7
Rubenstein, E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397267-5.00220-x · Cited by 5
An overview of neurodegenerative diseases
Muthukumar, S., Babu, H. W. S., & Subramaniam, M. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29898-1.00019-8 · Cited by 3
Genetic aspects of pediatric nephrotic syndrome and anti-nephrin antibodies
Horinouchi, T., Nozu, K., & Iijima, K. (2025) · Clinical and Experimental Nephrology · doi:10.1007/s10157-025-02645-4 · Cited by 5
Loebermann, M., Reisinger, E. C., Zettl, U. K., & Winkelmann, A. (2014) · Nervenheilkunde · doi:10.1055/s-0038-1627755 · Cited by 3
HHV-6A and HHV-6B in Autoimmune Disease
Broccolo, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-62703-2.00010-0 · Cited by 3
Modified models to distinguish central nervous system demyelinating diseases with brain lesions
Chen, B., Qin, C., Ji, S., Tian, D., Zhang, M., & Bu, B. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102965 · Cited by 4
Ladakis, D. C., & Bhargava, P. (2023) · CNS Drugs · doi:10.1007/s40263-023-00986-w · Cited by 6
In silico prioritisation of microRNA-associated common variants in multiple sclerosis
Fashina, I. A., McCoy, C. E., & Furney, S. J. (2023) · Human Genomics · doi:10.1186/s40246-023-00478-4 · Cited by 4
“This condition leads to periods of neurological disability in patients and is the cause of most non-traumatic neurological injury in young adults [1, 2].”
BackgroundThe HLA-DRB1 alleles effects on multiple sclerosis: a systematic review
Lima, T. F. R., Braga, V. L. L., Silva, J. T. D., Simplício, G. N., de Oliveira, S. Á. A., Barros, R. R., Pereira, J. B., Peixoto, F. S. D. N., da Silva, C. G. L., dos Santos, M. D. S. V., et al. (2015) · International Archives of Medicine · doi:10.3823/1687 · Cited by 4
“It presents with a variety of pathological process, such as demyelination, axonal injury and inflammation, with auto-reactive T cells [3, 4, 2].”
BackgroundO’Shea, J. J., Gadina, M., Siegel, R. M., & Farber, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00013-9 · Cited by 4
Lin, M. L., & Lin, W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041779 · Cited by 4
“Genetic predisposition is strongly supported by familial aggregation data [9–12].”
Protein Hypercitrullination in CNS Demyelinating Disease Reversed by PAD Inhibition
Moscarello, M. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8317-5_11 · Cited by 3
Clustering subjects in genetic studies with Self Organizing Maps
Aristodimou, A., Antoniades, A., & Pattichis, C. S. (2012) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2012.6399731 · Cited by 2
“Many studies indicated that there is an association among the HLA region and MS using single locus association testing [25]–[28].”
BackgroundAssociation Between HLA-A*02 Genotype and Multiple Sclerosis in Khuzestan Province, Iran
Ghanavati, R., Shafiei, M., & Galehdari, H. (2018) · Jundishapur Journal of Health Sciences · doi:10.5812/jjhs.59769 · Cited by 2
“Monozygotic twins are by birth genetically identical and 30% concordance rate in monozygotic twins indicates that additional factors such as virus infections, diet, exposure to sunlight, and geographical distribution can be involved in trigger and development of multiple sclerosis (21, 22).”
BackgroundMultiple sclerosis and neuromyelitis optica spectrum disorders
Ionescu, R.-B., Willis, C. M., Nicaise, A. M., Krzak, G., Hamel, R., Peruzzotti‐Jametti, L., & Pluchino, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00051-4 · Cited by 2
Selected Aspects of the Neuroimmunology of Cell Therapies for Neurologic Disease
Ransohoff, R. M. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200352 · Cited by 3
Yazdanpanah, M., Jalilian, N., Zadeh, R. A., Sahraian, M. A., & Noori–Daloii, M. R. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1860964 · Cited by 2
Drug Therapies for the Treatment of Multiple Sclerosis
Ryan, M. A. (2009) · Journal of Infusion Nursing · doi:10.1097/nan.0b013e3181a1a895 · Cited by 2
“Monozygotic twins who share all their genetic material, however, have a much higher risk of 25% to 30%.(5) Currently, the human leukocyte antigen chromosomal region has garnered the most attention as a contributor to MS development.”
BackgroundInfluentialThe role of gut microbiota and diet in experimental autoimmune encephalitis and multiple sclerosis
Okuno, T., Nakatsuji, Y., Kinoshita, M., Takata, K., Koda, T., Yamashita, K., Nanba, A., & Mochizuki, H. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12270 · Cited by 2
“Since butyrate production is linked to increased Treg cell populations, this could suggest a mechanism by which gut microbiome alterations would predispose individuals to developing MS. Additionally, MS patients receiving glatiramer acetate treatment demonstrated a difference in the abundance of Bacteroidaceae, Faecal…”
BackgroundInfluentialVITAMIN D AND MULTIPLE SCLEROSIS (REVIEW ARTICLE)
Asghar, A. H., Amini, H. A., Pakdaman, H., & Sahraian, M. A. (2014) · Cited by 2
Rahal, E. A., Fayad, L., Jaber, D. F., Kherlopian, A., Yamout, B., & Abdelnoor, A. M. (2014) · Research in Immunology An International Journal · doi:10.5171/2014.562663 · Cited by 2
“These include particular alleles of the interleukin-2 and interleukin-7 receptor αchain genes, IL2RA and IL7RA respectively, among various others (Sawcer, 2008, Hafler et al., 2007, Oksenberg et al., 2008, Sawcer et al., 2011).”
BackgroundIntracellular Calcium Assays in Dissociated Primary Cortical Neurons
Kaur, N., Thompson, D. V., Judd, D., Piper, D. R., & Mastro, R. G. D. (2009) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-60761-292-6_7 · Cited by 2
Basic Epigenetic Mechanisms and Phenomena
Hassler, M. R., Redl, E., Hudson, Q. J., Miller, W. J., & Egger, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802208-5.00001-1 · Cited by 6
Jager, P. L. D. (2012) · Wiley eBooks · doi:10.1002/9781119963714.ch3 · Cited by 2
Altas, B., Georgiou, P., Onisiforou, M., Zanos, P., & Onisiforou, A. (2025) · bioRxiv · doi:10.1101/2025.11.03.686445 · Cited by 1
“Genome-wide association studies have identified more than 200 MS risk loci, with the strongest signal arising from HLA-DRB1* 15:01 10 .”
Demyelination and Remyelination: General Principles
Niu, J., Verkhratsky, A., Butt, A. M., & Yi, C. (2025) · Advances in neurobiology · doi:10.1007/978-3-031-87919-7_9 · Cited by 3
Molavizade, S., Ashtari, F., Dehghani, F., Karimi, Z., Mahjoubi, M., & Zare, N. (2025) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2025.2534453 · Cited by 1
“[34] In addition, T cells have been shown to play a significant role in the autoimmune demye-lination process in MS. [35] Interferons are signaling molecules that regulate immune responses.”
Onisiforou, A. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag097 · Cited by 1
“Genome-wide association studies have identified numerous MS risk loci, with the strongest association linked to the HLA-DRB1 *15:01 allele, which plays a critical role in antigen presentation and T-cell activation [23].”
Why Is MS a More Frequent Complication of EBV Infection in Females?
Dunn, S. E., Álvarez‐Sánchez, N., & Steinman, L. (2026) · Immunological Reviews · doi:10.1111/imr.70115 · Cited by 1
Genetik und molekulare Untersuchungen bei MS
Lindberg, R., Naegelin, Y., Kühle, J., & Kappos, L. (2010) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2010.07212 · Cited by 2
Transcriptome Profiling in Autoimmune Diseases
Collares, C. V. A., & Donadi, E. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-11985-4_8 · Cited by 1
HLA DRB5*01 Association Survey with Multiple Sclerosis in Khuzestan Province of Iran
Pakdehi, T. L., Shafiei, M., & Galehdari, H. (2017) · Zahedan Journal of Research in Medical Sciences · doi:10.5812/zjrms.9186 · Cited by 2
“The human leukocyte antigen (HLA) is the human version of MHC and the strongest susceptibility locus for MS [27].”
BackgroundWallin, M. T., & Kurtzke, J. F. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00049-9 · Cited by 1
Correale, J. D. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8903-1_8 · Cited by 1
Interferon-β1b in der Multiple-Sklerose-Therapie: Mehr als 20 Jahre klinische Erfahrung
Hartung, H. ‐., Haas, J., Meergans, M., Tracik, F. M., & Ortler, S. (2013) · Der Nervenarzt · doi:10.1007/s00115-013-3781-0 · Cited by 2
Multiple Sklerose und andere autoimmune ZNS-Erkrankungen
Kroner, A., Kleinschnitz, C., Stadelmann, C., Raab, P., Stangel, M., Trebst, C., Voß, E. V., & Cordes, A.-L. (2011) · Springer eBooks · doi:10.1007/978-3-642-20477-7_1 · Cited by 4
Association between CD127 Gene Polymorphism and Susceptibility to Multiple Sclerosis
Alsahebfosoul, F. (2016) · SOJ Immunology · doi:10.15226/2372-0948/4/2/00150 · Cited by 2
“AlthoughIL-7Rα or CD-127 SNP has been investigated in previous studies, their result were controversial [6,7] and it has also been shown that frequencies of SNP polymorphisms in genetically autoimmune diseases such as MS vary in different ethnic populations in some studies [8].”
ResultGenética de la esclerosis múltiple: papel del HLA-DRB1 en la susceptibilidad y expresión fenotípica
Pinel, R., & María, L. (2010) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 2
Multiple Sclerosis Progression: a clinical, genetic, and environmental investigation
George, M. F. (2014) · eScholarship (California Digital Library) · Cited by 1
Damage and Repair in Experimental Cortical Demyelination
Garea‐Rodríguez, E. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3318 · Cited by 1
Cohen, J. A., & Rudick, R. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9781139023986.004
Klinische Neurogenetik: DNA-Diagnostik und Beratungsaspekte
Epplen, J. T., & Hoffjan, S. (2011) · Springer eBooks · doi:10.1007/978-3-642-16920-5_3
Metadata
- Authors
- Oksenberg, J. R., Baranzini, S. E., Sawcer, S., & Hauser, S. L.
- Affiliations
- University of California, San Francisco (US)
- University of Cambridge (GB)
- Corresponding author
- Oksenberg, Jorge R.
- Hauser, Stephen L.
- Venue
- Nature Reviews Genetics
- Published
- 2008-06-10
- Volume
- 9
- Issue
- 7
- Pages
- 516-526
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W1991500494
- Cited by
- 347
- References
- 125
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 7 · 2020: 11 · 2019: 7 · 2018: 10 · 2017: 15 · 2016: 15 · 2015: 22 · 2014: 27 · 2013: 20 · 2012: 22
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic susceptibility, single nucleotide polymorphisms, genome-wide association study, HLA region, gene-environment interaction, autoimmune demyelinating disease, pathogenesis, susceptibility genes, neuroimaging
- MeSH terms
- Animals, HLA Antigens, Humans, Multiple Sclerosis, Genome, Human, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.